Company Filing History:
Years Active: 2023
Title: Sudhir Chakravarthi: Innovator in Pharmaceutical Compositions
Introduction
Sudhir Chakravarthi is a notable inventor based in Manalapan, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that target specific antibodies. His work is instrumental in advancing therapeutic options for various medical conditions.
Latest Patents
Sudhir Chakravarthi holds a patent for "Compositions comprising an anti-LAG-3 antibody or an anti-LAG-3 antibody and an anti-PD-1 or anti-PD-L1 antibody." This patent provides pharmaceutical compositions that include either an anti-LAG-3 antibody or an anti-LAG-3 antibody combined with an anti-PD-1 or anti-PD-L1 antibody. The compositions also incorporate a buffering agent, stabilizing or bulking agent, and a surfactant. Additionally, the patent outlines methods for using these compositions, which can be delivered through vials, syringes, intravenous bags, or kits.
Career Highlights
Sudhir Chakravarthi is associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role at the company has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His innovative work has the potential to impact patient care significantly.
Collaborations
Sudhir has collaborated with esteemed colleagues such as Lori S. Burton and William Ying. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.
Conclusion
Sudhir Chakravarthi's contributions to pharmaceutical compositions demonstrate his commitment to innovation in medicine. His patent work and collaborations highlight the importance of teamwork in achieving significant advancements in healthcare.